|1.||Palumbo, Antonio: 37 articles (12/2015 - 10/2005)|
|2.||Pfreundschuh, Michael: 25 articles (10/2014 - 01/2002)|
|3.||Boccadoro, Mario: 24 articles (12/2015 - 10/2005)|
|4.||Gascoyne, Randy D: 20 articles (09/2015 - 08/2005)|
|5.||Coiffier, Bertrand: 20 articles (04/2015 - 01/2002)|
|6.||Petrucci, Maria Teresa: 17 articles (12/2015 - 01/2002)|
|7.||Bringhen, Sara: 17 articles (10/2014 - 03/2006)|
|8.||Engert, Andreas: 17 articles (01/2014 - 01/2002)|
|9.||Small, Eric J: 16 articles (10/2015 - 10/2004)|
|10.||Ryan, Charles J: 16 articles (10/2015 - 03/2007)|
|1.||Nephrotic Syndrome (Syndrome, Nephrotic)
02/20/1988 - "Complete initial remission of steroid responsive nephrotic syndrome can be obtained with half the standard prednisone dose, but the short course is followed by a higher rate of relapses, that require repeated prednisone administrations. "
03/01/1975 - " Thirty-four patients had been treated with prednisone; initial complete remission of the nephrotic syndrome occurred in only 4 patients and partial remission in 10. "
05/15/1971 - "Five of the elderly patients with minimal change lesion were treated with prednisone-in four a complete remission from the nephrotic syndrome followed, while the fifth patient's course is unknown.These"
04/01/2009 - "Among the adult Chinese patients with MSNS-HBV who completed this study, there were no significant differences in remission rates of idiopathic nephrotic syndrome between the standard prednisone regimen and the combination of MMF and a reduced prednisone dose. "
08/02/1980 - "Seven patients with slight but definite proliferative changes in the glomeruli achieved complete remission of the nephrotic syndrome when treated with prednisone. "
02/10/2015 - "Right atrial lymphoma: rapid relief of TV obstruction by prednisone."
11/01/1999 - "A favorable response of the subcutaneous induration to prednisone treatment does not exclude the diagnosis of lymphoma; therefore, it does not supersede the need of a pathological evaluation. "
09/01/1992 - "Prednisone with or without COPBLAM/IMVP-16 treatment in AILD-type lymphoma leads to complete remissions in about half of the patients and in long-term, disease-free survival for one third."
01/01/1990 - "We conclude that in this patient AILD and prednisone administration constituted favoring factors for the development of an extranodal lymphoma."
02/01/1984 - "Hypothalamic-pituitary-adrenal function in patients receiving intermittent high dose prednisone therapy for lymphoma."
|3.||Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
07/01/1981 - "Four patients with diffuse histiocytic lymphoma (group 1) received prednisone for 5 days every 3 weeks for five courses, and five patients with Hodgkin's disease (group 2) received prednisone for 14 days every 4 weeks for six courses. "
04/01/1983 - "The patient was treated with cyclophosphamide and prednisone with a good clinical response, but within two years, histiocytic lymphoma developed. "
09/01/1983 - "Subacute polyneuropathy that responded to prednisone was the initial symptom in two patients, one of whom was later found to have histiocytic lymphoma and the other, chronic lymphocytic leukemia. "
11/08/2012 - "TP53 mutation is an independent marker of poor prognosis in patients with diffuse large B-cell lymphoma (DLBCL) treated with cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone (CHOP) therapy. "
12/01/2007 - "The CHOP (cyclophosphamide/doxorucibin/vincristine/prednisone) regimen has been established as the standard treatment for diffuse large B-cell lymphoma (DLBCL). "
|4.||Non-Hodgkin Lymphoma (Lymphosarcoma)
01/01/1959 - "[A case of reticulosarcoma treated with large doses of prednisone]."
10/02/1957 - "[Massive dosage of prednisone in lymphogranuloma, lymphosarcoma and reticulum cell sarcoma]."
02/01/1957 - "[Reticulosarcoma of the scapula; treatment with delta cortisone]."
09/01/2013 - "Treatments for high-, intermediate-, and low-grade lymphomas were divided into 4 groups: absence of treatment, chemotherapy with or without hydroxydaunorubicin, and only prednisone. "
09/01/2005 - "This therapy was modified from CHOP in the treatment of patients with non-Hodgkin's lymphoma: CTX 600 mg/m(2), VCR 1.1 mg/m(2) were administrated by intravenous infusion every 2-4 weeks, prednisone was given orally at 1 mg.kg(-1).d(-1) for seven days after each infusion. "
01/01/1994 - "The purposes of this study were (1) to estimate the response rate of alternate-day high dose prednisone in patients with relapsing and refractory multiple myeloma; (2) to measure the rate of GR levels; and (3) to correlate the response of prednisone with GR status. "
01/01/1975 - "A study was designed to evaluate the effectiveness of prednisone therapy in poor-risk patients with multiple myeloma. "
05/01/2002 - "Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients."
01/01/1994 - "Alternate-day high-dose prednisone was well tolerated and may provide palliative benefit for a subset of patients with relapsing and refractory multiple myeloma. "
01/01/1994 - "Prednisone is an active drug in the treatment of multiple myeloma. "
|1.||Drug Therapy (Chemotherapy)
|3.||Combination Drug Therapy (Combination Chemotherapy)